Long-term daily temozolomide with dose-dependent efficacy in MGMT promotor methylation negative recurrent high-grade astrocytoma
Crossref DOI link: https://doi.org/10.1007/s00280-017-3415-5
Published Online: 2017-08-08
Published Print: 2017-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhou, Zhengqiu
Howard, Tracy A.
Villano, John L. http://orcid.org/0000-0001-5583-0093
License valid from 2017-08-08